Johnson & Johnson (JNJ) is recalling Tylenol products because of a musty odor, the company’s third such recall in 12 months.
J&J is yanking a line of Tylenol 8-hour caplets containing 127,728 bottles after customers complained of a musty smell…
There’s a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than …
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Continue reading J&J to Ac…
In testimony before Congress Thursday, Johnson & Johnson’s CEO apologized for the problems that have beset his company, including the quality issues with its children’s medicines and the “phantom recall” of a batch of Motrin. …